These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 32164894)
1. TAVR in Low-Risk Patients: FDA Approval, the New NCD, and Shared Decision-Making. Coylewright M; Forrest JK; McCabe JM; Nazif TM J Am Coll Cardiol; 2020 Mar; 75(10):1208-1211. PubMed ID: 32164894 [No Abstract] [Full Text] [Related]
2. Transcatheter Aortic Valve Replacement for Patients at Low Surgical Risk-Selective or Ubiquitous? Reardon MJ; O'Gara PT; Leon MB JAMA Cardiol; 2020 Jan; 5(1):7-8. PubMed ID: 31721990 [No Abstract] [Full Text] [Related]
3. The March of Transcatheter Aortic Valve Replacement Therapy-US Food and Drug Administration Perspectives on Device Approval for Patients at Low Surgical Risk. Wu C; Vasseur B; Maisel W JAMA Cardiol; 2020 Jan; 5(1):5-6. PubMed ID: 31721988 [No Abstract] [Full Text] [Related]
4. Is it time to refresh the heart team? New paradigms for shared decision making. Yeoh J; MacCarthy P Heart; 2021 Apr; 107(8):674-681. PubMed ID: 33109709 [No Abstract] [Full Text] [Related]
5. Long-term outlook for transcatheter aortic valve replacement. Durko AP; Osnabrugge RL; Kappetein AP Trends Cardiovasc Med; 2018 Apr; 28(3):174-183. PubMed ID: 28838702 [TBL] [Abstract][Full Text] [Related]
7. Utilization and outcomes of transcatheter aortic valve replacement in the United States shortly after device approval. Young MN; Elmariah S; Kennedy KF; Inglessis I; Yeh RW Catheter Cardiovasc Interv; 2017 Nov; 90(5):830-838. PubMed ID: 28326675 [TBL] [Abstract][Full Text] [Related]
8. Considerations and Recommendations for the Introduction of Objective Performance Criteria for Transcatheter Aortic Heart Valve Device Approval. Head SJ; Mylotte D; Mack MJ; Piazza N; van Mieghem NM; Leon MB; Kappetein AP; Holmes DR Circulation; 2016 May; 133(21):2086-93. PubMed ID: 27217434 [TBL] [Abstract][Full Text] [Related]
9. Two-year survival of patients screened for transcatheter aortic valve replacement with potentially malignant incidental findings in initial body computed tomography. Stachon P; Kaier K; Milde S; Pache G; Sorg S; Siepe M; von zur Mühlen C; Zirlik A; Beyersdorf F; Langer M; Zehender M; Bode C; Reinöhl J Eur Heart J Cardiovasc Imaging; 2015 Jul; 16(7):731-7. PubMed ID: 25759083 [TBL] [Abstract][Full Text] [Related]
10. Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic Severe Aortic Stenosis. Waksman R; Rogers T; Torguson R; Gordon P; Ehsan A; Wilson SR; Goncalves J; Levitt R; Hahn C; Parikh P; Bilfinger T; Butzel D; Buchanan S; Hanna N; Garrett R; Asch F; Weissman G; Ben-Dor I; Shults C; Bastian R; Craig PE; Garcia-Garcia HM; Kolm P; Zou Q; Satler LF; Corso PJ J Am Coll Cardiol; 2018 Oct; 72(18):2095-2105. PubMed ID: 30170075 [TBL] [Abstract][Full Text] [Related]
12. Impact of CMS coverage decision on access to transcatheter aortic valve replacement. O'Neill BP; O'Neill WW; Williams D; Cohen MG; Heldman AW; Macon C; Martinez CA; Alfonso CE; Clark PM; Velasquez O; Seo D; Clermont PG; Moscucci M Catheter Cardiovasc Interv; 2014 Jul; 84(1):114-21. PubMed ID: 24436032 [TBL] [Abstract][Full Text] [Related]
13. Update on transcatheter aortic valve replacement. Abdel-Wahab M; El-Mawardy M; Richardt G Trends Cardiovasc Med; 2015 Feb; 25(2):154-61. PubMed ID: 25453986 [TBL] [Abstract][Full Text] [Related]
14. Feasibility of transcatheter aortic valve replacement in low-risk patients with symptomatic severe aortic stenosis: Rationale and design of the Low Risk TAVR (LRT) study. Rogers T; Torguson R; Bastian R; Corso P; Waksman R Am Heart J; 2017 Jul; 189():103-109. PubMed ID: 28625366 [TBL] [Abstract][Full Text] [Related]
15. Choice of Treatment for Aortic Valve Stenosis in the Era of Transcatheter Aortic Valve Replacement in Eastern Denmark (2005 to 2015). De Backer O; Luk NH; Olsen NT; Olsen PS; Søndergaard L JACC Cardiovasc Interv; 2016 Jun; 9(11):1152-8. PubMed ID: 27209252 [TBL] [Abstract][Full Text] [Related]
16. Complications after Transfemoral Transcatheter Aortic Valve Replacement with a Balloon-Expandable Prosthesis: The Importance of Preventative Measures and Contingency Planning. Chakravarty T; Jilaihawi H; Doctor N; Fontana G; Forrester JS; Cheng W; Makkar R Catheter Cardiovasc Interv; 2018 Apr; 91(5):E29-E42. PubMed ID: 23436313 [TBL] [Abstract][Full Text] [Related]
17. Heart Team therapeutic decision-making and treatment in severe aortic valve stenosis. Thyregod HG; Holmberg F; Gerds TA; Ihlemann N; Søndergaard L; Steinbrüchel DA; Olsen PS Scand Cardiovasc J; 2016 Jun; 50(3):146-53. PubMed ID: 26825285 [TBL] [Abstract][Full Text] [Related]
19. Expanding the indications for transcatheter aortic valve implantation: is it time to treat low risk patients? De Backer O; Søndergaard L J Cardiovasc Surg (Torino); 2018 Jun; 59(3):370-372. PubMed ID: 29206005 [No Abstract] [Full Text] [Related]
20. Transapical Transcatheter Aortic Valve Replacement Is Associated With Increased Cardiac Mortality in Patients With Left Ventricular Dysfunction: Insights From the PARTNER I Trial. Elmariah S; Fearon WF; Inglessis I; Vlahakes GJ; Lindman BR; Alu MC; Crowley A; Kodali S; Leon MB; Svensson L; Pibarot P; Hahn RT; Thourani VH; Palacios IF; Miller DC; Douglas PS; Passeri JJ; JACC Cardiovasc Interv; 2017 Dec; 10(23):2414-2422. PubMed ID: 29217004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]